Mayo Clinic Platform and Techcyte Collaborate to Revolutionize Global Pathology

Tuesday, January 09, 2024

Mayo Clinic Platform and Techcyte have joined forces to revolutionize global pathology, leveraging cutting-edge technologies and innovative approaches to healthcare. Together, they are developing a digital pathology platform that aims to transform pathology practices on a global scale. This platform, rooted in artificial intelligence and advanced technical solutions, will enable healthcare organizations worldwide to economically transition to digital pathology, enhancing efficiency and accuracy.

The digital pathology platform, offered as a software-as-a-service solution, builds on Techcyte's successful clinical pathology platform. It establishes an open, AI-enabled anatomic pathology ecosystem that follows industry standards and prioritizes workflow efficiency. The platform's design facilitates collaboration among pathologists, LIS vendors, slide scanner manufacturers, storage providers, AI experts, biopharmaceutical companies, and laboratories.

This collaborative effort goes beyond previous clinical pathology initiatives between Mayo Clinic and Techcyte, where they digitized diagnostic testing in lab medicine. By combining Mayo Clinic's diagnostic expertise with Techcyte's digital workflows, this partnership aims to shape the future of both clinical and anatomical pathology practices, benefiting pathologists, their clinical colleagues, and ultimately, the patients they serve.





Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024